Payments to Acquire Property, Plant, and Equipment of Mersana Therapeutics, Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Mersana Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • Mersana Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Mersana Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $132,000, a 94% decline from 2023.
  • Mersana Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $2,168,000, a 1.3% decline from 2022.
  • Mersana Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $2,197,000, a 239% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$132,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $132,000 -$779,000 -86% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $911,000 +$582,000 +177% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $329,000 +$215,000 +189% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $114,000 +$49,000 +75% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $65,000 -$307,000 -83% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $372,000 +$105,000 +39% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $267,000 -$204,000 -43% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $471,000 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1

Mersana Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $132,000 -$2,036,000 -94% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
2023 $2,168,000 -$29,000 -1.3% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $2,197,000 +$1,549,000 +239% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $648,000 +$175,000 +37% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $473,000 -$132,000 -22% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $605,000 -$765,000 -56% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $1,370,000 +$227,000 +20% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $1,143,000 +$59,000 +5.4% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $1,084,000 +$465,000 +75% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2019 2018 FY
2015 $619,000 01 Jan 2015 31 Dec 2015 10-K 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.